Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Nov. 30, 2021	Nov. 30, 2020
Cash flows from operating activities:
Net (loss) income	$ (28,567)	$ 14,890
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	8,978	8,224
Amortization of debt discount	208	508
Bad debt expense (recovery)	201	(385)
Reduction in the carrying amount of the right of use asset	1,007	836
Loss on forward contracts	232	61
Equity in income of equity investees	(6,964)	(4,506)
Distribution of income from equity investees	7,603	4,248
Deferred income tax (benefit) expense	(578)	4,187
Non-cash compensation adjustment	(337)	(455)
Stock based compensation expense	694	1,454
Changes in operating assets and liabilities:
Accounts receivable	(27,372)	(78,692)
Inventory	(36,344)	(31,406)
Receivables from vendors	(122)	(19)
Prepaid expenses and other	(2,486)	(6,465)
Investment securities-trading	337	455
Accounts payable, accrued expenses, accrued sales incentives, contract liabilities, and other liabilities	73,903	83,049
Income taxes payable	(401)	1,388
Net cash used in operating activities	(10,008)	(2,628)
Cash flows from investing activities:
Purchases of property, plant, and equipment	(3,046)	(3,510)
Purchase of acquired business	(30,406)	(11,000)
Net cash used in investing activities	(33,452)	(14,510)
Cash flows from financing activities:
Principal payments on finance lease obligation	(323)	(470)
Repayment of bank obligations	(375)	(20,375)
Borrowings on bank obligations	1,656	20,000
Deferred financing costs	(667)	(260)
Withholding taxes paid on net issuance of stock award	(857)
Settlement of restricted stock units		575
Purchase of treasury stock	(1,220)
Proceeds from the issuance of subsidiary shares to non-controlling interest	2,069
Proceeds from the issuance of long-term debt to non-controlling interest	4,877
Net cash provided by (used in) financing activities	5,160	(1,680)
Effect of exchange rate changes on cash	58	2,730
Net decrease in cash and cash equivalents	(38,242)	(16,088)
Cash and cash equivalents at beginning of period	59,404	37,425
Cash and cash equivalents at end of period	$ 21,162	$ 21,337